EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Validation of robust radiobiological optimization algorithms based on the mixed beam model for intensity-modulated carbon-ion therapy

Masashi Yagi iD, Toshiro Tsubouchi, Noriaki Hamatani, Masaaki Takashina, Naoto Saruwatari, Kazumasa Minami, Yushi Wakisaka, Shinichiro Fujitaka, Shusuke Hirayama, Hideaki Nihongi, Azusa Hasegawa, Masahiko Koizumi und 3 weitere

PLOS ONE · 2023

DOI: 10.1371/journal.pone.0288545 ↗

Kurz gefasst

Fachartikel in der Zeitschrift PLOS ONE, 2023. Verfasst von Masashi Yagi und 14 weiteren Autor:innen. Beteiligte Einrichtung: Department of Carbon Ion Radiotherapy, Osaka University Graduate School of Medicine, Suita-shi, Osaka, Japan. Hauptthemen laut MEDLINE: Radiotherapy, Intensity-Modulated, Heavy Ion Radiotherapy, Proton Therapy. Die Arbeit wurde bisher 15-mal zitiert (Crossref) und nennt 36 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Japan Society for the Promotion of Science.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Currently, treatment planning systems (TPSs) that can compute the intensities of intensity-modulated carbon-ion therapy (IMCT) using scanned carbon-ion beams are limited. In the present study, the computational efficacy of the newly designed IMCT algorithms was analyzed for the first time based on the mixed beam model with respect to the physical and biological doses; moreover, the validity and effectiveness of the robust radiobiological optimization were verified. A dose calculation engine was independently generated to validate a clinical dose determined in the TPS. A biological assay was performed using the HSGc-C5 cell line to validate the calculated surviving fraction (SF). Both spot control (SC) and voxel-wise worst-case scenario (WC) algorithms were employed for robust radiobiological optimization followed by their application in a Radiation Therapy Oncology Group benchmark phantom under homogeneous and heterogeneous conditions and a clinical case for range and position errors. Importantly, for the first time, both SC and WC algorithms were implemented in the integrated TPS platform that can compute the intensities of IMCT using scanned carbon-ion beams for robust radiobiological optimization. For assessing the robustness, the difference between the maximum and minimum values of a dose–volume histogram index in the examined error scenarios was considered as a robustness index. The relative biological effectiveness (RBE) determined by the independent dose calculation engine exhibited a −0.6% difference compared with the RBE defined by the TPS at the isocenter, whereas the measured and the calculated SF were similar. Regardless of the objects, compared with the conventional IMCT, the robust radiobiological optimization enhanced the sensitivity of the examined error scenarios by up to 19% for the robustness index. The computational efficacy of the novel IMCT algorithms was verified according to the mixed beam model with respect to the physical and biological doses. The robust radiobiological optimizations lowered the impact of range and position uncertainties considerably in the examined scenarios. The robustness of the WC algorithm was more enhanced compared with that of the SC algorithm. Nevertheless, the SC algorithm can be used as an alternative to the WC IMCT algorithm with respect to the computational cost.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Radiotherapy, Intensity-ModulatedHeavy Ion RadiotherapyProton TherapyRadiotherapy Planning, Computer-AssistedAlgorithmsCarbonRadiotherapy Dosage

Substanzen

Carbon

Autor:innen und Institutionen

  • Department of Carbon Ion Radiotherapy, Osaka University Graduate School of Medicine, Suita-shi, Osaka, Japan.
  • Department of Medical Physics, Osaka Heavy Ion Therapy Center, Osaka-shi, Osaka, Japan.
  • Department of Medical Physics and Engineering, Osaka University Graduate School of Medicine, Suita-shi, Osaka, Japan.
  • Department of Radiation Technology, Osaka Heavy Ion Therapy Center, Osaka-shi, Osaka, Japan.
  • Hitachi, Ltd., Research & Development Group, Hitachi-shi, Ibaraki, Japan.
  • Hitachi, Ltd., Healthcare Innovation Division/Healthcare Business Division, Kashiwa-shi, Chiba, Japan.

ORCID-Profile: Masashi Yagi

Förderung

  • Japan Society for the Promotion of Science

Zitieren

APA

Yagi, M., Tsubouchi, T., Hamatani, N., Takashina, M., Saruwatari, N., Minami, K., Wakisaka, Y., Fujitaka, S., Hirayama, S., Nihongi, H., Hasegawa, A., Koizumi, M., Shimizu, S., Ogawa, K., & Kanai, T. (2023). Validation of robust radiobiological optimization algorithms based on the mixed beam model for intensity-modulated carbon-ion therapy. PLOS ONE. https://doi.org/10.1371/journal.pone.0288545

Vancouver

Yagi M, Tsubouchi T, Hamatani N, Takashina M, Saruwatari N, Minami K, et al. Validation of robust radiobiological optimization algorithms based on the mixed beam model for intensity-modulated carbon-ion therapy. PLOS ONE. 2023. doi:10.1371/journal.pone.0288545

BibTeX
@article{Yagi2023,
  author = {Yagi, Masashi and Tsubouchi, Toshiro and Hamatani, Noriaki and Takashina, Masaaki and Saruwatari, Naoto and Minami, Kazumasa and Wakisaka, Yushi and Fujitaka, Shinichiro and Hirayama, Shusuke and Nihongi, Hideaki and Hasegawa, Azusa and Koizumi, Masahiko and Shimizu, Shinichi and Ogawa, Kazuhiko and Kanai, Tatsuaki},
  title = {Validation of robust radiobiological optimization algorithms based on the mixed beam model for intensity-modulated carbon-ion therapy},
  journal = {PLOS ONE},
  year = {2023},
  doi = {10.1371/journal.pone.0288545}
}
Kostenlos starten →